The nanoneedle biosensor is a cost-effective, versatile, ultrasensitive and high-throughput nanoelectronics device. This device measures the electrical impedance of cells from a single drop of blood.
This test is able to distinguish ME/CFS patients from healthy controls.
An analysis of over 40 ME/CFS patients and controls has established that cells from the blood of ME/CFS patients exhibit a characteristic impedance pattern when subjected to salt stress that is significantly different than the controls.
Future tests of this device will be made to: